A Retrospective Study on Human Leukocyte Antigen Types and Haplotypes in a South African Population
© 2021 College of American Pathologists..
CONTEXT.—: Human leukocyte antigen (HLA) is a polymorphic protein of the immune system with a central role in organ transplantation. Organ recipients can be sensitized against HLA from previous exposure, which increases the likelihood of antidonor immune responses and subsequently organ rejection. HLA matching represents an attractive option to improve graft function, reduce sensitization of recipients in first transplantations, and improve organ allocation.
OBJECTIVE.—: To examine the feasibility of the reintroduction of HLA matching into the criteria in the Johannesburg program, we retrospectively assessed HLA types in our donor population.
DESIGN.—: HLA types of 782 deceased and related living donors from 2015 until 2019 were recorded and analyzed to identify the most common HLA types and haplotypes. A virtual crossmatch was also done to examine the anti-HLA antibodies in the recipient population compared with the common HLA types identified in this study.
RESULTS.—: Of the most common HLA types identified, at least 1 was present in 732 (93.6%) of the renal donors assessed. The virtual crossmatch confirmed that most recipients are sensitized against most donors, and this greatly impacts the number of recipients who can receive organ transplants.
CONCLUSIONS.—: This study determined the most common HLA types and haplotypes in a South African organ donor population. This information, combined with the evidence suggesting the immunogenic potential of these common types, the high number of recipients with antibodies against common HLA types, and the ethnic distribution of the donor and recipient populations, informs the recommendation that the pretransplantation workup should not reinclude HLA matching.
| Errataetall: |
ErratumIn: Arch Pathol Lab Med. 2021 Aug 1;145(8):918. - PMID 34313716 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:145 |
|---|---|
| Enthalten in: |
Archives of pathology & laboratory medicine - 145(2021), 4 vom: 01. Apr., Seite 441-447 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gandini, Anastasia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 31.05.2021 Date Revised 30.11.2021 published: Print ErratumIn: Arch Pathol Lab Med. 2021 Aug 1;145(8):918. - PMID 34313716 Citation Status MEDLINE |
|---|
| doi: |
10.5858/arpa.2020-0042-OA |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315321369 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315321369 | ||
| 003 | DE-627 | ||
| 005 | 20231225154648.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.5858/arpa.2020-0042-OA |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315321369 | ||
| 035 | |a (NLM)32960949 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gandini, Anastasia |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A Retrospective Study on Human Leukocyte Antigen Types and Haplotypes in a South African Population |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 31.05.2021 | ||
| 500 | |a Date Revised 30.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a ErratumIn: Arch Pathol Lab Med. 2021 Aug 1;145(8):918. - PMID 34313716 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 College of American Pathologists. | ||
| 520 | |a CONTEXT.—: Human leukocyte antigen (HLA) is a polymorphic protein of the immune system with a central role in organ transplantation. Organ recipients can be sensitized against HLA from previous exposure, which increases the likelihood of antidonor immune responses and subsequently organ rejection. HLA matching represents an attractive option to improve graft function, reduce sensitization of recipients in first transplantations, and improve organ allocation | ||
| 520 | |a OBJECTIVE.—: To examine the feasibility of the reintroduction of HLA matching into the criteria in the Johannesburg program, we retrospectively assessed HLA types in our donor population | ||
| 520 | |a DESIGN.—: HLA types of 782 deceased and related living donors from 2015 until 2019 were recorded and analyzed to identify the most common HLA types and haplotypes. A virtual crossmatch was also done to examine the anti-HLA antibodies in the recipient population compared with the common HLA types identified in this study | ||
| 520 | |a RESULTS.—: Of the most common HLA types identified, at least 1 was present in 732 (93.6%) of the renal donors assessed. The virtual crossmatch confirmed that most recipients are sensitized against most donors, and this greatly impacts the number of recipients who can receive organ transplants | ||
| 520 | |a CONCLUSIONS.—: This study determined the most common HLA types and haplotypes in a South African organ donor population. This information, combined with the evidence suggesting the immunogenic potential of these common types, the high number of recipients with antibodies against common HLA types, and the ethnic distribution of the donor and recipient populations, informs the recommendation that the pretransplantation workup should not reinclude HLA matching | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a HLA Antigens |2 NLM | |
| 650 | 7 | |a Isoantibodies |2 NLM | |
| 700 | 1 | |a Mampeule, Nakampe |e verfasserin |4 aut | |
| 700 | 1 | |a Jugwanth, Sarika |e verfasserin |4 aut | |
| 700 | 1 | |a Gededzha, Maemu P |e verfasserin |4 aut | |
| 700 | 1 | |a Mayne, Elizabeth |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Archives of pathology & laboratory medicine |d 1978 |g 145(2021), 4 vom: 01. Apr., Seite 441-447 |w (DE-627)NLM000037508 |x 1543-2165 |7 nnns |
| 773 | 1 | 8 | |g volume:145 |g year:2021 |g number:4 |g day:01 |g month:04 |g pages:441-447 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.5858/arpa.2020-0042-OA |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 145 |j 2021 |e 4 |b 01 |c 04 |h 441-447 | ||